Skip to content

Earnings yield at other companies

Pfizer logo
PfizerPFE
6.8%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
-4.7%
Philip Morris International logo
Philip Morris InternationalPM
4.3%+1.0pp

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

Based on trailing twelve months.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's earnings yield?
Achieve Life Sciences (ACHV) reported earnings yield of -33.2% in Q1 2026.
How has Achieve Life Sciences's earnings yield changed year-over-year?
Achieve Life Sciences's earnings yield increased by 33.4% year-over-year, from -49.8% to -33.2%.
What is the long-term trend for Achieve Life Sciences's earnings yield?
Over 5 years (2020 to 2025), Achieve Life Sciences's earnings yield has grown at a 1.4% compound annual growth rate (CAGR), from -19.2% to -20.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.